Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Autoimmune Disorders

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 308 articles:
HTML format

Single Articles

    January 2024
  1. XUE H, Zeng L, He H, Xu D, et al
    Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0291685.
    PubMed     Abstract available

  2. EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
    Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
    PLoS One. 2024;19:e0296661.
    PubMed     Abstract available

  3. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed     Abstract available

  4. DASGUPTA SK, Gollamudi J, Rivera S, Poche RA, et al
    beta2-glycoprotein I promotes the clearance of circulating mitochondria.
    PLoS One. 2024;19:e0293304.
    PubMed     Abstract available

  5. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    PubMed     Abstract available

  6. YANG H, Chen Z, Huang J, Li S, et al
    AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
    PLoS One. 2024;19:e0291594.
    PubMed     Abstract available

  7. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    PubMed     Abstract available

  8. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    PubMed     Abstract available

  9. MITTAL R, McKenna K, Keith G, Lemos JRN, et al
    A systematic review of the association of Type I diabetes with sensorineural hearing loss.
    PLoS One. 2024;19:e0298457.
    PubMed     Abstract available

  10. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    PubMed     Abstract available

  11. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    PubMed     Abstract available

    January 2023
  12. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    PubMed     Abstract available

  13. DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
    Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    PLoS One. 2023;18:e0276423.
    PubMed     Abstract available

  14. DE SONNAVILLE WFC, Steenks MH, Zuithoff NPA, Wulffraat NM, et al
    Reliability and measurement error of anterior maximum voluntary bite force in children with juvenile idiopathic arthritis and healthy children.
    PLoS One. 2023;18:e0280763.
    PubMed     Abstract available

  15. KANSUTTIVIWAT C, Niprapan P, Tantiworawit A, Norasetthada L, et al
    Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
    PLoS One. 2023;18:e0279450.
    PubMed     Abstract available

  16. VAN TIENHOVEN R, Vu AN, Kaddis JS, Roep BO, et al
    Low risk for diabetic complications in type 1 diabetes patients carrying a protective insulin gene variant.
    PLoS One. 2023;18:e0280872.
    PubMed     Abstract available

  17. HARARI G, Gurevich M, Dolev M, Zilkha Falb R, et al
    Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study.
    PLoS One. 2023;18:e0280515.
    PubMed     Abstract available

  18. GON Y, Kandou T, Tsuruyama T, Iwasaki T, et al
    Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model.
    PLoS One. 2023;18:e0279389.
    PubMed     Abstract available

  19. GRANJA DOMINGUEZ A, Romero Sevilla R, Aleman A, Duran C, et al
    Study for the validation of the FeetMe(R) integrated sensor insole system compared to GAITRite(R) system to assess gait characteristics in patients with multiple sclerosis.
    PLoS One. 2023;18:e0272596.
    PubMed     Abstract available

  20. VICH-PEREZ P, Abanades-Herranz JC, Mora-Navarro G, Carrasco-Sayalero AM, et al
    Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study.
    PLoS One. 2023;18:e0281657.
    PubMed     Abstract available

  21. CABANILLAS-LAZO M, Cruzalegui-Bazan C, Pascual-Guevara M, Quispe-Vicuna C, et al
    Clinical and imagenologic significance of the neutrophil-to-lymphocyte ratio in neuromyelitis optica spectrum disorder: A systematic review with meta-analysis.
    PLoS One. 2023;18:e0281064.
    PubMed     Abstract available

  22. SOFUE T, Oguchi H, Yazawa M, Tsujita M, et al
    Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
    PLoS One. 2023;18:e0281945.
    PubMed     Abstract available

  23. BARAK-CORREN Y, Castro VM, Javitt S, Nock MK, et al
    Improving risk prediction for target subpopulations: Predicting suicidal behaviors among multiple sclerosis patients.
    PLoS One. 2023;18:e0277483.
    PubMed     Abstract available

  24. SWERDEL JN, Ramcharran D, Hardin J
    Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.
    PLoS One. 2023;18:e0281929.
    PubMed     Abstract available

  25. ALAZWARI A, Johnstone A, Tafakori L, Abdollahian M, et al
    Predicting the development of T1D and identifying its Key Performance Indicators in children; a case-control study in Saudi Arabia.
    PLoS One. 2023;18:e0282426.
    PubMed     Abstract available

  26. LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
    Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
    PLoS One. 2023;18:e0281979.
    PubMed     Abstract available

  27. ERSOY T, Hocaoglu E
    A 3-DoF robotic platform for the rehabilitation and assessment of reaction time and balance skills of MS patients.
    PLoS One. 2023;18:e0280505.
    PubMed     Abstract available

  28. RAGY O, Rautemaa V, Smith A, Brenchley P, et al
    Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
    PLoS One. 2023;18:e0281726.
    PubMed     Abstract available

  29. SOKRATOUS D, Charalambous CC, Papanicolaou EZ, Michailidou K, et al
    Investigation of in-phase bilateral exercise effects on corticospinal plasticity in relapsing remitting multiple sclerosis: A registered report single-case concurrent multiple baseline design across five subjects.
    PLoS One. 2023;18:e0272114.
    PubMed     Abstract available

  30. MISAKI T, Naka S, Suzuki H, Lee M, et al
    cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
    PLoS One. 2023;18:e0282367.
    PubMed     Abstract available

  31. CHOI SJ, Ahn SM, Oh JS, Hong S, et al
    Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
    PLoS One. 2023;18:e0282852.
    PubMed     Abstract available

  32. FEHMI J, Davies AJ, Antonelou M, Keddie S, et al
    Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
    PLoS One. 2023;18:e0281156.
    PubMed     Abstract available

  33. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
    Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: The Hypo-METRICS app.
    PLoS One. 2023;18:e0283148.
    PubMed     Abstract available

  34. LIPKA S, Ostendorf L, Schneider U, Hiepe F, et al
    Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis.
    PLoS One. 2023;18:e0282919.
    PubMed     Abstract available

  35. SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
    Multiple sclerosis and COVID-19: A retrospective study in Iran.
    PLoS One. 2023;18:e0283538.
    PubMed     Abstract available

  36. LAICHINGER K, Bombach P, Dunschede J, Ruschil C, et al
    No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke.
    PLoS One. 2023;18:e0283476.
    PubMed     Abstract available

  37. LEDEGANCK KJ, Van Eyck A, Wouters K, Vermeiren E, et al
    Urinary epidermal growth factor reflects vascular health in boys with either obesity or type 1 diabetes. A role for renin, or beyond?
    PLoS One. 2023;18:e0283716.
    PubMed     Abstract available

  38. ZAFEIRI L, Akerfeldt T, Tolf A, Carlson K, et al
    Anti-Mullerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    PLoS One. 2023;18:e0284288.
    PubMed     Abstract available

  39. WANG Y, Hurley A, De Giorgi M, Tanner MR, et al
    Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
    PLoS One. 2023;18:e0283996.
    PubMed     Abstract available

  40. NOPPARAT J, Khuituan P, Peerakietkhajorn S, Teanpaisan R, et al
    Probiotics of Lacticaseibacillus paracasei SD1 and Lacticaseibacillus rhamnosus SD11 attenuate inflammation and beta-cell death in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2023;18:e0284303.
    PubMed     Abstract available

  41. HANGANU AR, Constantin A, Moise ES, Niculae CM, et al
    Peripheral nervous system involvement associated with COVID-19. A systematic review of literature.
    PLoS One. 2023;18:e0283827.
    PubMed     Abstract available

  42. BENINI S, Pellegrini E, Descovich C, Lugaresi A, et al
    Burden and resources in caregivers of people with multiple sclerosis: A qualitative study.
    PLoS One. 2023;18:e0265297.
    PubMed     Abstract available

  43. MARTINS ALMDS, Bernardes AB, Ferreira VA, Wanderley DC, et al
    In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy.
    PLoS One. 2023;18:e0284789.
    PubMed     Abstract available

  44. CRAWFORD MP, Borcherding N, Karandikar NJ
    IL-17 cytokines preferentially act on naive CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes.
    PLoS One. 2023;18:e0285166.
    PubMed     Abstract available

  45. HAMILTON P, Blaikie K, Roberts SA, Gittins M, et al
    Membranous nephropathy in the UK Biobank.
    PLoS One. 2023;18:e0281795.
    PubMed     Abstract available

  46. LEE SH, Lee S, Lee J, Lee JK, et al
    Effective encoder-decoder neural network for segmentation of orbital tissue in computed tomography images of Graves' orbitopathy patients.
    PLoS One. 2023;18:e0285488.
    PubMed     Abstract available

  47. SU K, Jia Z, Wu Y, Sun Y, et al
    A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study.
    PLoS One. 2023;18:e0285915.
    PubMed     Abstract available

  48. AHMAD POUZI NA, Shaharir SS, Mohd Tamil A, Mustafar R, et al
    Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    PLoS One. 2023;18:e0285461.
    PubMed     Abstract available

  49. COBB J, Soliman SSM, Retuerto M, Quijano JC, et al
    Changes in the gut microbiota of NOD mice in response to an oral Salmonella-based vaccine against type 1 diabetes.
    PLoS One. 2023;18:e0285905.
    PubMed     Abstract available

  50. HORVATH M, Herold Z, Kustel M, Tamas L, et al
    Changes in the cochlear and retrocochlear parts of the auditory system in 19-39 and 40-60 years old patients with type 1 diabetes mellitus.
    PLoS One. 2023;18:e0285740.
    PubMed     Abstract available

  51. MACHADO-ALBA JE, Machado-Duque ME, Gaviria-Mendoza A, Duarte-Rey C, et al
    Clinical characterization of a cohort of patients treated for systemic lupus erythematosus in Colombia: A retrospective study.
    PLoS One. 2023;18:e0285889.
    PubMed     Abstract available

  52. STAHL D, Friberg E
    Formal help for persons with multiple sclerosis-Background factors associated with usage of personal assistance and home help in Sweden.
    PLoS One. 2023;18:e0286010.
    PubMed     Abstract available

  53. MISTRY S, Gouripeddi R, Reno CM, Abdelrahman S, et al
    Detecting hypoglycemia-induced electrocardiogram changes in a rodent model of type 1 diabetes using shape-based clustering.
    PLoS One. 2023;18:e0284622.
    PubMed     Abstract available

  54. ZAK R, Navasardyan L, Hunak J, Martinu J, et al
    PTPN22 intron polymorphism rs1310182 (c.2054-852T>C) is associated with type 1 diabetes mellitus in patients of Armenian descent.
    PLoS One. 2023;18:e0286743.
    PubMed     Abstract available

  55. EVEREST E, Uygunoglu U, Tutuncu M, Bulbul A, et al
    Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers.
    PLoS One. 2023;18:e0287463.
    PubMed     Abstract available

  56. STEYN LV, Drew D, Vlachos D, Huey B, et al
    Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabetic Rattus norvegicus.
    PLoS One. 2023;18:e0278794.
    PubMed     Abstract available

  57. MEDEIROS MCS, Souza KSC, Galdino OA, Cobucci RN, et al
    Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol.
    PLoS One. 2023;18:e0287753.
    PubMed     Abstract available

  58. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    PubMed     Abstract available

  59. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
    PLoS One. 2023;18:e0285599.
    PubMed     Abstract available

  60. TURTON JL, Brinkworth GD, Parker HM, Lim D, et al
    Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial.
    PLoS One. 2023;18:e0288440.
    PubMed     Abstract available

  61. NAISBY J, Wilson-Menzfeld G, Baker K, Morris R, et al
    Yoga and Multiple Sclerosis: Maintaining engagement in physical activity.
    PLoS One. 2023;18:e0288319.
    PubMed     Abstract available

    Deficient AMPK activity contributes to hyperexcitability in peripheral nociceptive sensory neurons and thermal hyperalgesia in lupus mice.
    PLoS One. 2023;18:e0288356.
    PubMed     Abstract available

  63. VILADES E, Cordon B, Perez-Velilla J, Orduna E, et al
    Evaluation of multiple sclerosis severity using a new OCT tool.
    PLoS One. 2023;18:e0288581.
    PubMed     Abstract available

  64. FRAGKIADAKI E, Cotterill N, Rice C, Smith JA, et al
    Evaluation of the feasibility and acceptability of an integrative group psychological intervention for people with Multiple Sclerosis: A study protocol.
    PLoS One. 2023;18:e0288295.
    PubMed     Abstract available

  65. WANG TY, Chang FP, Yang AH, Ka SM, et al
    Key pathological features characterize minimal change disease-like IgA nephropathy.
    PLoS One. 2023;18:e0288384.
    PubMed     Abstract available

  66. GOUGH A, Sitch A, Ferris E, Marshall T, et al
    Within-subject variation of HbA1c: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0289085.
    PubMed     Abstract available

  67. MACHADO A, Azad A, Pettersson E, Hillert J, et al
    Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references.
    PLoS One. 2023;18:e0288998.
    PubMed     Abstract available

  68. MEIJBOOM R, York EN, Kampaite A, Harris MA, et al
    Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
    PLoS One. 2023;18:e0288967.
    PubMed     Abstract available

  69. HERNANDEZ M, Ramon-Julvez U, Vilades E, Cordon B, et al
    Explainable artificial intelligence toward usable and trustworthy computer-aided diagnosis of multiple sclerosis from Optical Coherence Tomography.
    PLoS One. 2023;18:e0289495.
    PubMed     Abstract available

  70. RAZIA R, Majeed F, Amin R, Mukhtar S, et al
    Predictive value of alpha-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.
    PLoS One. 2023;18:e0285022.
    PubMed     Abstract available

  71. DING J, Li C, Shu K, Chen W, et al
    Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer.
    PLoS One. 2023;18:e0289960.
    PubMed     Abstract available

  72. HARRIS VK, Wollowitz J, Greenwald J, Carlson AL, et al
    Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis.
    PLoS One. 2023;18:e0290069.
    PubMed     Abstract available

  73. DEFRES S, Tharmaratnam K, Michael BD, Ellul M, et al
    Clinical predictors of encephalitis in UK adults-A multi-centre prospective observational cohort study.
    PLoS One. 2023;18:e0282645.
    PubMed     Abstract available

  74. ULLAH S, Zheng Z, Rahman W, Ullah F, et al
    A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids.
    PLoS One. 2023;18:e0290576.
    PubMed     Abstract available

  75. GOOCH AM, Chowdhury SS, Zhang PM, Hu ZM, et al
    Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.
    PLoS One. 2023;18:e0290460.
    PubMed     Abstract available

  76. TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
    Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
    PLoS One. 2023;18:e0291063.
    PubMed     Abstract available

  77. LIN DY, Andreotti AH
    Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
    PLoS One. 2023;18:e0290872.
    PubMed     Abstract available

  78. MONSTED MO, Holm LJ, Buschard K, Haupt-Jorgensen M, et al
    Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice.
    PLoS One. 2023;18:e0289258.
    PubMed     Abstract available

  79. HOWLAND S, Huber J, Aicken C
    Designing a brief and simple intervention to help young people with type 1 diabetes to live well: Protocol for developing a novel intervention with participation from young people.
    PLoS One. 2023;18:e0285300.
    PubMed     Abstract available

  80. SIKORSKI P, Li Y, Cheema M, Wolfe GI, et al
    Serum metabolomics of treatment response in myasthenia gravis.
    PLoS One. 2023;18:e0287654.
    PubMed     Abstract available

  81. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
    Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    PLoS One. 2023;18:e0292233.
    PubMed     Abstract available

  82. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    PubMed     Abstract available

  83. PARK SS, Mai M, Ploszaj M, Cai H, et al
    Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
    PLoS One. 2023;18:e0291948.
    PubMed     Abstract available

  84. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    PubMed     Abstract available

  85. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
    The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
    PLoS One. 2023;18:e0293908.
    PubMed     Abstract available

  86. ABIDOV M, Sokolova K, Danilova I, Baykenova M, et al
    Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently.
    PLoS One. 2023;18:e0294432.
    PubMed     Abstract available

  87. CHENG CW, Fang WF, Lin JD
    Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
    PLoS One. 2023;18:e0289345.
    PubMed     Abstract available

  88. SUZUKI K, Iwata D, Namba K, Hase K, et al
    Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
    PLoS One. 2023;18:e0294745.
    PubMed     Abstract available

  89. WALLE M, Arkew M, Asmerom H, Tesfaye A, et al
    The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295011.
    PubMed     Abstract available

  90. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    PubMed     Abstract available

  91. HARVENGT AA, Polle OG, Martin M, van Maanen A, et al
    Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.
    PLoS One. 2023;18:e0294982.
    PubMed     Abstract available

  92. TRENTIN-SONODA M, Cheff V, Gutsol A, Hebert RL, et al
    Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
    PLoS One. 2023;18:e0295284.
    PubMed     Abstract available

  93. LORD SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al
    Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
    PLoS One. 2023;18:e0293268.
    PubMed     Abstract available

  94. FALLAH M, Najafi A, Balighi K, Daneshpazhooh M, et al
    Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
    PLoS One. 2023;18:e0295026.
    PubMed     Abstract available

  95. ABDULLAHI AS, Suliman A, Khan MA, Khair H, et al
    Temporal trends of hemoglobin among pregnant women: The Mutaba'ah study.
    PLoS One. 2023;18:e0295549.
    PubMed     Abstract available

  96. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
    Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
    PLoS One. 2023;18:e0288366.
    PubMed     Abstract available

    January 2022
  97. YU F, Zhou X, Jin X, Zhao S, et al
    Rational construction of controllable autoimmune diabetes model depicting clinical features.
    PLoS One. 2022;17:e0260100.
    PubMed     Abstract available

  98. OKOTH K, Subramanian A, Chandan JS, Adderley NJ, et al
    Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study.
    PLoS One. 2022;17:e0261769.
    PubMed     Abstract available

  99. ARIF B, Arif Z, Ahmad J, Perveen K, et al
    Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
    PLoS One. 2022;17:e0262233.
    PubMed     Abstract available

  100. KALKOWSKI L, Golubczyk D, Kwiatkowska J, Domzalska M, et al
    Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement.
    PLoS One. 2022;17:e0262677.
    PubMed     Abstract available

  101. WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
    Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
    PLoS One. 2022;17:e0262480.
    PubMed     Abstract available

  102. HORTON MK, McCurdy S, Shao X, Bellesis K, et al
    Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
    PLoS One. 2022;17:e0262093.
    PubMed     Abstract available

  103. SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
    Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
    PLoS One. 2022;17:e0262160.
    PubMed     Abstract available

  104. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    PubMed     Abstract available

  105. PETROVA T, Bennett K, Nanda S, Strickson S, et al
    Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
    PLoS One. 2022;17:e0263151.
    PubMed     Abstract available

  106. LERKVALEEKUL B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, et al
    Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    PLoS One. 2022;17:e0263536.
    PubMed     Abstract available

  107. AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
    Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
    PLoS One. 2022;17:e0263606.
    PubMed     Abstract available

  108. ALAZWARI A, Abdollahian M, Tafakori L, Johnstone A, et al
    Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia.
    PLoS One. 2022;17:e0264118.
    PubMed     Abstract available

  109. BEDI S, Richardson TM, Jia B, Saab H, et al
    Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
    PLoS One. 2022;17:e0261103.
    PubMed     Abstract available

  110. TANIGUCHI H, Nirengi S, Ishihara K, Sakane N, et al
    Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0263774.
    PubMed     Abstract available

  111. QUIGLEY M, Earnest A, Szwarcbard N, Wischer N, et al
    Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
    PLoS One. 2022;17:e0263511.
    PubMed     Abstract available

  112. LI JY, Sun XH, Shen DC, Yang XZ, et al
    Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
    PLoS One. 2022;17:e0266529.
    PubMed     Abstract available

  113. MEKONNEN GA, Gelaye KA, Gebreyohannes EA, Abegaz TM, et al
    Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study.
    PLoS One. 2022;17:e0264626.
    PubMed     Abstract available

  114. KONG X, Diao S, Xu H, Sun J, et al
    Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.
    PLoS One. 2022;17:e0266265.
    PubMed     Abstract available

  115. MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
    Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
    PLoS One. 2022;17:e0266203.
    PubMed     Abstract available

  116. QEADAN F, Tingey B, Egbert J, Pezzolesi MG, et al
    The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data.
    PLoS One. 2022;17:e0266809.
    PubMed     Abstract available

  117. MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
    Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266492.
    PubMed     Abstract available

  118. CHEN X, Zhang Y, Luo Z, Wu Y, et al
    Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0264705.
    PubMed     Abstract available

  119. TANA MM, Klepper A, Lyden A, Pisco AO, et al
    Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
    PLoS One. 2022;17:e0264307.
    PubMed     Abstract available

  120. NGAMJANYAPORN P, Worawichawong S, Pisitkun P, Khiewngam K, et al
    Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    PLoS One. 2022;17:e0263778.
    PubMed     Abstract available

  121. CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
    PLoS One. 2022;17:e0264123.
    PubMed     Abstract available

  122. KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
    Do Hungarian multiple sclerosis care units fulfil international criteria?
    PLoS One. 2022;17:e0264328.
    PubMed     Abstract available

  123. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    PubMed     Abstract available

  124. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    PubMed     Abstract available

  125. ROVO A, Cantoni N, Samii K, Rufer A, et al
    Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    PLoS One. 2022;17:e0267342.
    PubMed     Abstract available

  126. FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
    Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    PLoS One. 2022;17:e0264489.
    PubMed     Abstract available

  127. ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
    Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
    PLoS One. 2022;17:e0264708.
    PubMed     Abstract available

  128. LIN X, Liu Y, Chen Y, Huang X, et al
    Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
    PLoS One. 2022;17:e0265017.
    PubMed     Abstract available

  129. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    PubMed     Abstract available

  130. GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
    A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
    PLoS One. 2022;17:e0267245.
    PubMed     Abstract available

  131. RAHIM T, Levinson MA, Carufe KEW, Burak M, et al
    The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.
    PLoS One. 2022;17:e0267913.
    PubMed     Abstract available

  132. ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
    Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
    PLoS One. 2022;17:e0267504.
    PubMed     Abstract available

  133. WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
    Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
    PLoS One. 2022;17:e0266786.
    PubMed     Abstract available

  134. HIERL KV, Krause M, Kruber D, Sterker I, et al
    3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.
    PLoS One. 2022;17:e0265324.
    PubMed     Abstract available

  135. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    PubMed     Abstract available

  136. IIDA M, Ohtomo S, Wada NA, Ueda O, et al
    TNF-alpha induces Claudin-1 expression in renal tubules in Alport mice.
    PLoS One. 2022;17:e0265081.
    PubMed     Abstract available

  137. BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
    A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
    PLoS One. 2022;17:e0268475.
    PubMed     Abstract available

  138. ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
    Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
    PLoS One. 2022;17:e0268125.
    PubMed     Abstract available

  139. KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
    Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
    PLoS One. 2022;17:e0268783.
    PubMed     Abstract available

  140. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    PubMed     Abstract available

  141. COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
    Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
    PLoS One. 2022;17:e0269085.
    PubMed     Abstract available

  142. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    PubMed     Abstract available

  143. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    PubMed     Abstract available

  144. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
    PLoS One. 2022;17:e0269610.
    PubMed     Abstract available

  145. ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
    Optic neuritis: A South African hospital-based prospective study protocol.
    PLoS One. 2022;17:e0269514.
    PubMed     Abstract available

  146. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available

  147. MAROZOFF S, Mai A, Dehghan N, Sayre EC, et al
    Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.
    PLoS One. 2022;17:e0270142.
    PubMed     Abstract available

  148. HUANG Y, Wang WK, Zheng XM, Yang L, et al
    Decreased salivary alpha-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.
    PLoS One. 2022;17:e0269621.
    PubMed     Abstract available

  149. PETRZALKA M, Meluzinova E, Libertinova J, Mojzisova H, et al
    IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
    PLoS One. 2022;17:e0270607.
    PubMed     Abstract available

  150. ALBURNO H, Mercken L, de Vries H, Al Mohannadi D, et al
    Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study.
    PLoS One. 2022;17:e0270984.
    PubMed     Abstract available

  151. RASKIN E, Achiron A, Zloto O, Neuman R, et al
    Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
    PLoS One. 2022;17:e0264918.
    PubMed     Abstract available

  152. HAYASHI K, Sada KE, Asano Y, Katayama Y, et al
    Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
    PLoS One. 2022;17:e0270569.
    PubMed     Abstract available

  153. KRAUSE A, Lee K, Konig D, Faist M, et al
    Six weeks of whole-body vibration improves fine motor accuracy, functional mobility and quality of life in people with multiple sclerosis.
    PLoS One. 2022;17:e0270698.
    PubMed     Abstract available

  154. AFYOUNI H, Haris B, Syed N, Ahmed I, et al
    Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar.
    PLoS One. 2022;17:e0271182.
    PubMed     Abstract available

  155. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study.
    PLoS One. 2022;17:e0271055.
    PubMed     Abstract available

  156. ZANOTTO T, Rice LA, Sosnoff JJ
    Frailty among people with multiple sclerosis who are wheelchair users.
    PLoS One. 2022;17:e0271688.
    PubMed     Abstract available

  157. SHAH R, Mohammed YN, Koehler TJ, Kaur J, et al
    Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
    PLoS One. 2022;17:e0269466.
    PubMed     Abstract available

  158. BREW-SAM N, Desborough J, Parkinson A, Murugappan K, et al
    A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people.
    PLoS One. 2022;17:e0269925.
    PubMed     Abstract available

  159. LOPEZ ORTEGA JM, Martinez PS, Acevedo-Leon D, Capell NE, et al
    Anti-TSH receptor antibodies (TRAb): Comparison of two third generation automated immunoassays broadly used in clinical laboratories and results interpretation.
    PLoS One. 2022;17:e0270890.
    PubMed     Abstract available

  160. VITTURI BK, Rahmani A, Dini G, Montecucco A, et al
    Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0272156.
    PubMed     Abstract available

  161. UELAND GA, Ernes T, Vonheim Madsen T, Husebye ES, et al
    Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.
    PLoS One. 2022;17:e0272133.
    PubMed     Abstract available

  162. TU H, Li N, Liu W, Fan Z, et al
    Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0269371.
    PubMed     Abstract available

  163. PAPADIMITRIOU E, Boutzios G, Mathioudakis AG, Vlahos NF, et al
    Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0260759.
    PubMed     Abstract available

  164. QIU LNY, Cai SV, Chan D, Hess RS, et al
    Seasonality and geography of diabetes mellitus in United States of America dogs.
    PLoS One. 2022;17:e0272297.
    PubMed     Abstract available

  165. MAHMOUD RH, Fouad NA, Hefzy EM, Shaker OG, et al
    The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus.
    PLoS One. 2022;17:e0268176.
    PubMed     Abstract available

  166. MORRISON AE, Chong K, Senior PA, Lam A, et al
    A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    PLoS One. 2022;17:e0271096.
    PubMed     Abstract available

  167. HOHN A, McGurnaghan SJ, Caparrotta TM, Jeyam A, et al
    Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018.
    PLoS One. 2022;17:e0271110.
    PubMed     Abstract available

  168. CRABTREE E, Uribe K, Smith SM, Roberts D, et al
    Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.
    PLoS One. 2022;17:e0270972.
    PubMed     Abstract available

  169. LI Y, Yu X, Zhang W, Lv J, et al
    Epidemiological characteristics and pathological changes of primary glomerular diseases.
    PLoS One. 2022;17:e0272237.
    PubMed     Abstract available

  170. CHOI YJ, Kim C, Choi EW, Lee SH, et al
    MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    PLoS One. 2022;17:e0270416.
    PubMed     Abstract available

  171. SEKIGUCHI K, Ishizuchi K, Takizawa T, Motegi H, et al
    Anemia in female patients with myasthenia gravis.
    PLoS One. 2022;17:e0273720.
    PubMed     Abstract available

  172. STORRAR J, Chinnadurai R, Sinha S, Kalra PA, et al
    The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
    PLoS One. 2022;17:e0268421.
    PubMed     Abstract available

  173. VIROONLUECHA P, Egea-Lopez E, Santa J
    Evaluation of blood glucose level control in type 1 diabetic patients using deep reinforcement learning.
    PLoS One. 2022;17:e0274608.
    PubMed     Abstract available

  174. TAKASHI Y, Maeda Y, Toyokawa K, Oda N, et al
    Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes.
    PLoS One. 2022;17:e0274182.
    PubMed     Abstract available

  175. JOH K, Nakazato T, Hashiguchi A, Shimizu A, et al
    Structural modeling for Oxford histological classifications of immunoglobulin A nephropathy.
    PLoS One. 2022;17:e0268731.
    PubMed     Abstract available

  176. LAROCQUE JC, Gardy S, Sammut M, McBey DP, et al
    Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0273701.
    PubMed     Abstract available

  177. YOSHIKAWA H, Adachi Y, Nakamura Y, Kuriyama N, et al
    Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018.
    PLoS One. 2022;17:e0274161.
    PubMed     Abstract available

  178. CARREIRA M, Ruiz de Adana MS, Pinzon JL, Anarte-Ortiz MT, et al
    Internet-based Cognitive-behavioral therapy (CBT) for depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study): A randomized controlled trial protocol.
    PLoS One. 2022;17:e0274551.
    PubMed     Abstract available

  179. KUENDIG S, Kool J, Polhemus A, Schallert W, et al
    Three weeks of rehabilitation improves walking capacity but not daily physical activity in patients with multiple sclerosis with moderate to severe walking disability.
    PLoS One. 2022;17:e0274348.
    PubMed     Abstract available

  180. SMAOUI MR, Lafi A
    Leeno: Type 1 diabetes management training environment using smart algorithms.
    PLoS One. 2022;17:e0274534.
    PubMed     Abstract available

  181. NING L, Wang B
    Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0274565.
    PubMed     Abstract available

  182. ABUAF AF, Bunting SR, Klein S, Carroll T, et al
    Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
    PLoS One. 2022;17:e0274778.
    PubMed     Abstract available

  183. ALMAZROUEI R, Sharma C, Afandi B, Aldahmani KM, et al
    Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.
    PLoS One. 2022;17:e0264545.
    PubMed     Abstract available

  184. DING MY, Li B, Yang M, Zhai WS, et al
    Effectiveness of shengxuexiaoban capsules combined with glucocorticoid therapy for immune thrombocytopenia: A meta-analysis.
    PLoS One. 2022;17:e0275122.
    PubMed     Abstract available

  185. YAMAGUCHI M, Ito M, Sugiyama H, Iwagaitsu S, et al
    Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan.
    PLoS One. 2022;17:e0274483.
    PubMed     Abstract available

  186. GUIMARAES JAR, Furtado SDC, Lucas ACDS, Mori B, et al
    Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
    PLoS One. 2022;17:e0275016.
    PubMed     Abstract available

  187. JENSEN MH, Cichosz SL, Gustenhoff P, Nikontovic A, et al
    Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
    PLoS One. 2022;17:e0274626.
    PubMed     Abstract available

  188. STORRAR J, Gill-Taylor T, Chinnadurai R, Chrysochou C, et al
    A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.
    PLoS One. 2022;17:e0276053.
    PubMed     Abstract available

  189. MASIS L, Kanya L, Kiogora J, Kiapi L, et al
    Estimating treatment costs for uncomplicated diabetes at a hospital serving refugees in Kenya.
    PLoS One. 2022;17:e0276702.
    PubMed     Abstract available

  190. SELVARAJ MS, Paruchuri K, Haidermota S, Bernardo R, et al
    Genome-wide discovery for diabetes-dependent triglycerides-associated loci.
    PLoS One. 2022;17:e0275934.
    PubMed     Abstract available

  191. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    PubMed     Abstract available

  192. AMATYA M, Pant AD
    Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience.
    PLoS One. 2022;17:e0276172.
    PubMed     Abstract available

  193. DAVID BL, Ivan GJ, Emilio PE, Daniela MJ, et al
    Low serum uromodulin levels and their association with lupus flares.
    PLoS One. 2022;17:e0276481.
    PubMed     Abstract available

  194. CHEN W, Yu Y, Liu Y, Song C, et al
    Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats.
    PLoS One. 2022;17:e0277061.
    PubMed     Abstract available

  195. RICCI S, Perugia F, Piccini B, Lodi L, et al
    DR4/DQ2 haplotype confers susceptibility to T1DM with early clinical disease onset: A retrospective analysis in a tertiary-care hospital in Italy.
    PLoS One. 2022;17:e0276896.
    PubMed     Abstract available

  196. BAYARMUNKH O, Ganbold C, Das S, Davaatseren U, et al
    Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    PLoS One. 2022;17:e0277055.
    PubMed     Abstract available

  197. BOYARCHUK O, Dobrovolska L, Svystunovych H
    Selective immunoglobulin A deficiency in children with diabetes mellitus: Data from a medical center in Ukraine.
    PLoS One. 2022;17:e0277273.
    PubMed     Abstract available

  198. YANG B, Parker RB, Meibohm B, Temrikar ZH, et al
    Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis.
    PLoS One. 2022;17:e0278111.
    PubMed     Abstract available

  199. VALORI M, Lehikoinen J, Jansson L, Clancy J, et al
    High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls.
    PLoS One. 2022;17:e0278245.
    PubMed     Abstract available

  200. CROMER SJ, Chen V, Han C, Marshall W, et al
    Algorithmic identification of atypical diabetes in electronic health record (EHR) systems.
    PLoS One. 2022;17:e0278759.
    PubMed     Abstract available

  201. ALAZMI A, Viktor S, Erjavec M
    Exploring the determinants of mental health, wellbeing, and lifestyle in 8-11 year old children with type 1 diabetes and their healthy counterparts in Kuwait.
    PLoS One. 2022;17:e0272948.
    PubMed     Abstract available

  202. CLARKSON TC, Iguchi N, Xie AX, Malykhina AP, et al
    Differential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus.
    PLoS One. 2022;17:e0278918.
    PubMed     Abstract available

  203. BROOME CM, Hooda N, Su J, Jiang X, et al
    Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.
    PLoS One. 2022;17:e0276617.
    PubMed     Abstract available

  204. AL-KAFAJI G, Alwehaidah MS, Alsabbagh MM, Alharbi MA, et al
    Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple sclerosis.
    PLoS One. 2022;17:e0279237.
    PubMed     Abstract available

  205. PARK HY, Chae MK, Ko J, Kikkawa DO, et al
    Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
    PLoS One. 2022;17:e0279060.
    PubMed     Abstract available

  206. WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
    Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
    PLoS One. 2022;17:e0270875.
    PubMed     Abstract available

  207. BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
    Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.
    PLoS One. 2022;17:e0279132.
    PubMed     Abstract available

  208. LANDRUM KR, Pence BW, Gaynes BN, Dussault JM, et al
    The cross-sectional association of stressful life events with depression severity among patients with hypertension and diabetes in Malawi.
    PLoS One. 2022;17:e0279619.
    PubMed     Abstract available

    January 2021
  209. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    PubMed     Abstract available

  210. KATEWA A, Suto E, Hui J, Heredia J, et al
    The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
    PLoS One. 2021;16:e0244439.
    PubMed     Abstract available

  211. WILLETT K, Khan RS, Dine K, Wessel H, et al
    Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
    PLoS One. 2021;16:e0243862.
    PubMed     Abstract available

  212. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available

  213. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    PubMed     Abstract available

  214. ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
    Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
    PLoS One. 2021;16:e0245721.
    PubMed     Abstract available

  215. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    PubMed     Abstract available

  216. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available

  217. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    PubMed     Abstract available

  218. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    PubMed     Abstract available

  219. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    PubMed     Abstract available

  220. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    PubMed     Abstract available

  221. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    PubMed     Abstract available

  222. WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
    The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
    PLoS One. 2021;16:e0247173.
    PubMed     Abstract available

  223. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    PubMed     Abstract available

  224. HE J, Kong D, Yang Z, Guo R, et al
    Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
    PLoS One. 2021;16:e0247662.
    PubMed     Abstract available

  225. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available

  226. HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
    Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
    PLoS One. 2021;16:e0248937.
    PubMed     Abstract available

  227. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    PubMed     Abstract available

  228. GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
    Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    PLoS One. 2021;16:e0248965.
    PubMed     Abstract available

  229. WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
    Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
    PLoS One. 2021;16:e0247501.
    PubMed     Abstract available

  230. KIM SE, Kim J, Lee JY, Lee SB, et al
    Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
    PLoS One. 2021;16:e0249988.
    PubMed     Abstract available

  231. DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
    Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249611.
    PubMed     Abstract available

  232. MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
    Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    PLoS One. 2021;16:e0249592.
    PubMed     Abstract available

  233. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    PubMed     Abstract available

  234. ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
    Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
    PLoS One. 2021;16:e0247052.
    PubMed     Abstract available

  235. CHOI S, Spini M, Hua J, Harrison DM, et al
    Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2021;16:e0249973.
    PubMed     Abstract available

  236. LUU T, Cheung JF, Baccon J, Waldner H, et al
    Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2021;16:e0250340.
    PubMed     Abstract available

  237. SAKUNRANGSIT N, Metheepakornchai P, Kumpunya S, Greenblatt MB, et al
    Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model.
    PLoS One. 2021;16:e0250215.
    PubMed     Abstract available

  238. LIU GY, Wu Y, Kong FY, Ma S, et al
    BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.
    PLoS One. 2021;16:e0243014.
    PubMed     Abstract available

  239. SATITPITAKUL V, Rattanaphong T, Pruksakorn V
    Meibomian glands dropout in patients with inactive thyroid related orbitopathy.
    PLoS One. 2021;16:e0250617.
    PubMed     Abstract available

  240. STERNBACH S, West N, Singhal NK, Clements R, et al
    The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
    PLoS One. 2021;16:e0250486.
    PubMed     Abstract available

  241. GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
    Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
    PLoS One. 2021;16:e0250647.
    PubMed     Abstract available

  242. ALKHATEEB H, El Fathi A, Ghanbari M, Haidar A, et al
    Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
    PLoS One. 2021;16:e0248280.
    PubMed     Abstract available

  243. SENDIC S, Mansouri L, Lundberg S, Nopp A, et al
    B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
    PLoS One. 2021;16:e0248056.
    PubMed     Abstract available

  244. SHAHARIR SS, Chua SH, Mohd R, Mustafar R, et al
    Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
    PLoS One. 2021;16:e0248845.
    PubMed     Abstract available

  245. CANDADAI AA, Liu F, Fouda AY, Alfarhan M, et al
    Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis.
    PLoS One. 2021;16:e0247901.
    PubMed     Abstract available

  246. IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
    Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
    PLoS One. 2021;16:e0248549.
    PubMed     Abstract available

  247. WILSKI M, Brola W, Luniewska M, Tomczak M, et al
    The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
    PLoS One. 2021;16:e0248135.
    PubMed     Abstract available

  248. SATO H, Ichikawa D, Okada E, Suzuki T, et al
    Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    PLoS One. 2021;16:e0251294.
    PubMed     Abstract available

  249. LU Z, Liu W, Gao H, Chen W, et al
    Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251131.
    PubMed     Abstract available

  250. FATOYE F, Gebrye T, Svenson LW
    Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    PLoS One. 2021;16:e0251409.
    PubMed     Abstract available

  251. LIAO K, Chen K, Brett S, Gehman A, et al
    Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
    PLoS One. 2021;16:e0249049.
    PubMed     Abstract available

  252. CHARNIGA K, Cucunuba ZM, Walteros DM, Mercado M, et al
    Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017.
    PLoS One. 2021;16:e0252236.
    PubMed     Abstract available

  253. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    PubMed     Abstract available

  254. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available

  255. STOUGAARD EB, Winther SA, Amadid H, Frimodt-Moller M, et al
    Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
    PLoS One. 2021;16:e0254859.
    PubMed     Abstract available

  256. MECA-LALLANA JE, Maurino J, Perez-Miralles F, Forero L, et al
    Quantifying the patient s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
    PLoS One. 2021;16:e0255317.
    PubMed     Abstract available

  257. NEGASH Z, Berha AB, Shibeshi W, Ahmed A, et al
    Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0251709.
    PubMed     Abstract available

  258. HOFFMAN WH, Whelan SA, Lee N
    Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
    PLoS One. 2021;16:e0254116.
    PubMed     Abstract available

  259. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2021;16:e0257809.
    PubMed     Abstract available

  260. SWANN JW, Tayler S, Hall H, Sparrow R, et al
    Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
    PLoS One. 2021;16:e0257700.
    PubMed     Abstract available

  261. MCCALL JL, Blair HC, Blethen KE, Hall C, et al
    Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.
    PLoS One. 2021;16:e0249442.
    PubMed     Abstract available

  262. GAJ S, Ontaneda D, Nakamura K
    Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
    PLoS One. 2021;16:e0255939.
    PubMed     Abstract available

  263. KIRILMAZ OB, Salegaonkar AR, Shiau J, Uzun G, et al
    Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    PLoS One. 2021;16:e0254718.
    PubMed     Abstract available

  264. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
    PLoS One. 2021;16:e0254226.
    PubMed     Abstract available

  265. JOHNSON M, Ehlers S, Fernell E, Hajjari P, et al
    Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review.
    PLoS One. 2021;16:e0253844.
    PubMed     Abstract available

  266. BRATT G, Brannstrom J, Missalidis C, Nystrom T, et al
    Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
    PLoS One. 2021;16:e0254079.
    PubMed     Abstract available

  267. NGUYEN THP, Fagerland MW, Deyab G, Hjeltnes G, et al
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    PLoS One. 2021;16:e0253793.
    PubMed     Abstract available

  268. FAGBAMIGBE AF, Norrman E, Bergh C, Wennerholm UB, et al
    Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.
    PLoS One. 2021;16:e0253389.
    PubMed     Abstract available

  269. VAN DOORN WPTM, Foreman YD, Schaper NC, Savelberg HHCM, et al
    Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
    PLoS One. 2021;16:e0253125.
    PubMed     Abstract available

  270. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    PubMed     Abstract available

  271. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    PubMed     Abstract available

  272. WYSOCKA-MINCEWICZ M, Golebiewska J, Baszynska-Wilk M, Olechowski A, et al
    Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes.
    PLoS One. 2021;16:e0252588.
    PubMed     Abstract available

  273. WORAWICHAWONG S, Plumworasawat S, Liwlompaisan W, Sumethkul V, et al
    Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy.
    PLoS One. 2021;16:e0252638.
    PubMed     Abstract available

  274. PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
    Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
    PLoS One. 2021;16:e0250820.
    PubMed     Abstract available

  275. ROZYCKA J
    How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
    PLoS One. 2021;16:e0258740.
    PubMed     Abstract available

  276. PARIKH RV, Tan TC, Fan D, Law D, et al
    Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    PLoS One. 2021;16:e0257674.
    PubMed     Abstract available

  277. MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
    Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
    PLoS One. 2021;16:e0258017.
    PubMed     Abstract available

  278. NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
    The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256845.
    PubMed     Abstract available

  279. SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
    Multiple sclerosis reduces synchrony of the magnocellular pathway.
    PLoS One. 2021;16:e0255324.
    PubMed     Abstract available

  280. JANG SY, Choi SH, Kikkawa D, Lee EJ, et al
    Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    PLoS One. 2021;16:e0255344.
    PubMed     Abstract available

  281. GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
    Genetic susceptibility to multiple sclerosis in African Americans.
    PLoS One. 2021;16:e0254945.
    PubMed     Abstract available

  282. SIDDIG O, Mustafa MB, Kordofani Y, Gibson J, et al
    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
    PLoS One. 2021;16:e0254634.
    PubMed     Abstract available

  283. MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
    Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
    PLoS One. 2021;16:e0258437.
    PubMed     Abstract available

  284. TEZUKA Y, Eguchi-Ishimae M, Ozaki E, Ito T, et al
    Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    PLoS One. 2021;16:e0258090.
    PubMed     Abstract available

  285. LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
    Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    PLoS One. 2021;16:e0253337.
    PubMed     Abstract available

  286. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available

  287. KIM SS, Hudgins AD, Yang J, Zhu Y, et al
    A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    PLoS One. 2021;16:e0257265.
    PubMed     Abstract available

  288. OSAKI T, Souri M, Ichinose A
    Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
    PLoS One. 2021;16:e0257322.
    PubMed     Abstract available

  289. AHMAD I, Wergeland S, Oveland E, Bo L, et al
    A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    PLoS One. 2021;16:e0256155.
    PubMed     Abstract available

  290. NATHAN DM, Krause-Steinrauf H, Braffett BH, Arends VL, et al
    Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.
    PLoS One. 2021;16:e0257154.
    PubMed     Abstract available

  291. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    PubMed     Abstract available

  292. ALKETBI A, Basit S, Hamza N, Walton LM, et al
    The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    PLoS One. 2021;16:e0258752.
    PubMed     Abstract available

  293. PARUNYAKUL K, Srisuksai K, Charoenlappanit S, Phaonakrop N, et al
    Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2021;16:e0256140.
    PubMed     Abstract available

  294. SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
    Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    PLoS One. 2021;16:e0261050.
    PubMed     Abstract available

  295. VALORI M, Jansson L, Tienari PJ
    CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
    PLoS One. 2021;16:e0261002.
    PubMed     Abstract available

  296. ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
    Bacterial variation in the oral microbiota in multiple sclerosis patients.
    PLoS One. 2021;16:e0260384.
    PubMed     Abstract available

  297. RENAUD A, Caristan A, Seguin A, Agard C, et al
    Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.
    PLoS One. 2021;16:e0260196.
    PubMed     Abstract available

  298. BOCH K, Drager S, Zillikens D, Hudemann C, et al
    Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
    PLoS One. 2021;16:e0259586.
    PubMed     Abstract available

  299. HSU CY, Chueh YS, Kuo ML, Lee PT, et al
    Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
    PLoS One. 2021;16:e0261727.
    PubMed     Abstract available

  300. BLUTHGEN C, Patella M, Euler A, Baessler B, et al
    Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis.
    PLoS One. 2021;16:e0261401.
    PubMed     Abstract available

  301. COOLEN M, Broadley M, Hendrieckx C, Chatwin H, et al
    The impact of hypoglycemia on quality of life and related outcomes in children and adolescents with type 1 diabetes: A systematic review.
    PLoS One. 2021;16:e0260896.
    PubMed     Abstract available

  302. MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
    Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    PLoS One. 2021;16:e0261097.
    PubMed     Abstract available

  303. MANUWALD U, Schoffer O, Kugler J, Riemenschneider H, et al
    Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany.
    PLoS One. 2021;16:e0262171.
    PubMed     Abstract available

  304. CAREY IM, Banchoff E, Nirmalananthan N, Harris T, et al
    Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
    PLoS One. 2021;16:e0261983.
    PubMed     Abstract available

  305. MIDTHASSEL TC, Hansen AH
    Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.
    PLoS One. 2021;16:e0261471.
    PubMed     Abstract available

  306. CH'NG JH, Moll K, Wyss K, Hammar U, et al
    Enhanced virulence of Plasmodium falciparum in blood of diabetic patients.
    PLoS One. 2021;16:e0249666.
    PubMed     Abstract available

  307. GAUDILLIERE M, Marsot C, Balaire L, Groisne L, et al
    Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes.
    PLoS One. 2021;16:e0251693.
    PubMed     Abstract available

  308. LO CH, Wang YH, Tsai CF, Chan KC, et al
    Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
    PLoS One. 2021;16:e0251918.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.